谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

A Novel and Selective Oral PI3Kα/δ Inhibitor, TQ-B3525, in Patients with Relapsed And/or Refractory Follicular Lymphoma: A Phase II, Single-Arm, Open-Label Study.

Huaqing Wang,Aibin Liang,Jifeng Feng,Yanyan Liu,Zhengzi Qian,Da Gao,Xuehong Ran,Hui Zhou,Lihong Liu,Binghua Wang,Meiyun Fang,Hebing Zhou, Zhenqian Huang, Shi Tao,Zhuowen Chen,Liping Su,Hang Su,Yu Yang,Xiaobao Xie,Zhiming Li

Journal of Clinical Oncology（2024）

引用 0|浏览9
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要